Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Marc I. Uemura

Oncology
Willamette Valley Cancer and Research Institute
Oncology Associates Of Oregon P C
520 Country Club Pkwy, 
Eugene, OR 
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
Willamette Valley Cancer and Research Institute
Oncology Associates Of Oregon P C
520 Country Club Pkwy, 
Eugene, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Marc Uemura is an Oncologist in Eugene, Oregon. Dr. Uemura is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Melanoma, Chronic Familial Neutropenia, and Agranulocytosis. Dr. Uemura is currently accepting new patients.

His clinical research consists of co-authoring 16 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Student in an Organized Health Care Education/Training Program in CA
Hospital Affiliations
Sacred Heart Medical Center - Riverbend
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
ATRIO Health
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser
  • EPO
  • HMO
  • POS
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
Samaritan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

ONCOLOGY ASSOCIATES OF OREGON P C
520 Country Club Pkwy, Eugene, OR 97401
Call: 541-683-5001

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
Enrollment Status: Completed
Publish Date: January 22, 2025
Intervention Type: Drug, Other
Study Drugs: Tucatinib, Trastuzumab, Ramucirumab, Paclitaxel
Study Phase: Phase 2/Phase 3
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 31, 2024
Intervention Type: Drug, Device
Study Drugs: Gemcitabine, Nab-paclitaxel
Study Phase: Phase 3
A Phase III, Multicenter, Randomized, Double Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Canakinumab Versus Placebo as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II -IIIA and IIIB (T>5cm N2) Completely Resected (R0) Non-small Cell Lung Cancer (NSCLC)
A Phase III, Multicenter, Randomized, Double Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Canakinumab Versus Placebo as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II -IIIA and IIIB (T>5cm N2) Completely Resected (R0) Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Canakinumab
Study Phase: Phase 3
A Phase 1a / 1b, First-in-human, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-0903 Administered Daily for 21 Days to Patients With Advanced Solid Tumors
A Phase 1a / 1b, First-in-human, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-0903 Administered Daily for 21 Days to Patients With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: TP-0903
Study Phase: Phase 1
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
Enrollment Status: Terminated
Publish Date: January 20, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 4 Less Clinical Trials

16 Total Publications

Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.
Journal: Cancer discovery
Published: October 26, 2020
View All 16 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Stephen A. Williams
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Stephen A. Williams
Hematology Oncology | Hematology | Oncology

Steelhead Specialty Group PC

2880 Nw Stewart Pkwy, 
Roseburg, OR 
 (58.5 miles away)
541-229-4070
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Stephen Williams is a Hematologist Oncology specialist and a Hematologist in Roseburg, Oregon. Dr. Williams is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Cancer, Myelodysplastic Syndrome (MDS), Paget Disease of the Breast, and Clear Cell Sarcoma. Dr. Williams is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. John T. Fitzharris
Oncology | Hematology Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. John T. Fitzharris
Oncology | Hematology Oncology

Oncology Associates Of Oregon P C

520 Country Club Pkwy, 
Eugene, OR 
 (0.1 miles away)
541-683-5001
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Fitzharris is an Oncologist and a Hematologist Oncology provider in Eugene, Oregon. Dr. Fitzharris is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Pleuropulmonary Blastoma, Multiple Myeloma, Familial Pancreatic Cancer, and Pancreatic Cancer. Dr. Fitzharris is currently accepting new patients.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Herschel D. Wallen
Oncology
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Herschel D. Wallen
Oncology

Good Samaritan Hospital Corvallis

441 Nw Elks Dr, 
Corvallis, OR 
 (38.0 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Herschel Wallen is an Oncologist in Corvallis, Oregon. Dr. Wallen is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Thrombocytopenia, Lung Cancer, Pleuropulmonary Blastoma, and Paget Disease of the Breast. Dr. Wallen is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Uemura's expertise for a condition
ConditionClose
      • Advanced
      • Adult Soft Tissue Sarcoma
        Dr. Uemura is
        Advanced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Agranulocytosis
        Dr. Uemura is
        Advanced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      • Anal Cancer
        Dr. Uemura is
        Advanced
        . Learn about Anal Cancer.
        See more Anal Cancer experts
      • Appendix Cancer
        Dr. Uemura is
        Advanced
        . Learn about Appendix Cancer.
        See more Appendix Cancer experts
      • Bladder Cancer
        Dr. Uemura is
        Advanced
        . Learn about Bladder Cancer.
        See more Bladder Cancer experts
      • Breast Cancer
        Dr. Uemura is
        Advanced
        . Learn about Breast Cancer.
        See more Breast Cancer experts
      View All 39 Advanced Conditions
      • Experienced
      • Acinic Cell Carcinoma of Salivary Glands
        Dr. Uemura is
        Experienced
        . Learn about Acinic Cell Carcinoma of Salivary Glands.
        See more Acinic Cell Carcinoma of Salivary Glands experts
      • Acute Lymphoblastic Leukemia (ALL)
        Dr. Uemura is
        Experienced
        . Learn about Acute Lymphoblastic Leukemia (ALL).
        See more Acute Lymphoblastic Leukemia (ALL) experts
      • Acute Myeloblastic Leukemia with Maturation
        Dr. Uemura is
        Experienced
        . Learn about Acute Myeloblastic Leukemia with Maturation.
        See more Acute Myeloblastic Leukemia with Maturation experts
      • Acute Myeloblastic Leukemia without Maturation
        Dr. Uemura is
        Experienced
        . Learn about Acute Myeloblastic Leukemia without Maturation.
        See more Acute Myeloblastic Leukemia without Maturation experts
      • Acute Myeloid Leukemia (AML)
        Dr. Uemura is
        Experienced
        . Learn about Acute Myeloid Leukemia (AML).
        See more Acute Myeloid Leukemia (AML) experts
      • Adenoid Cystic Carcinoma
        Dr. Uemura is
        Experienced
        . Learn about Adenoid Cystic Carcinoma.
        See more Adenoid Cystic Carcinoma experts
      View All 109 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved